|
|
||||||||
4 Cytoplasmic Tail Required for Regulation of In Vivo Expansion of Murine Lymphoma Cells1


*
Institute of Medical Microbiology, Immunology, and Hygiene, Technische Universität, Munich, Germany;
Gesellschaft für Strahlung und Umweltforschung-Institut für Pathologie Neuherberg, Oberschleissheim, Germany; and
Department of Surgery, Klinikum rechts der Isar, Technische Universität, Munich, Germany
The binding of integrins to cognate ligands is tightly controlled
by intracellular signals. Conversely, integrin occupancy generates
biochemical signals inside the cell. The present study examined whether
concepts of integrin function established by in vitro analysis apply to
regulation of receptor function in complex biologic settings in vivo
using a mouse model of tumor metastasis. Integrin
4
subunits were truncated at amino acid Gln1014 (A4-1014),
preserving the conserved GFFKR motif, and at position
Glu1021 (A4-1021). In vitro adhesion assays revealed that
cytoplasmic tail truncations did not affect constitutive ligand binding
of
4 integrins, while agonist-induced adhesion was
abolished by the A4-1014, but not by the A4-1021, mutation. Inducible
ligand binding of
4 integrins was dependent on
cytoskeletal function, whereas constitutive adhesion was not. In vivo
metastasis formation assays demonstrated that expansion of murine T
lymphoma cells in spleen is strongly inhibited by the wild-type
4 subunit and the A4-1021 mutant. In contrast, the in
vivo phenotype of
4 integrin expression in lymphoma
cells was completely abrogated by the A4-1014 mutation. Cross-linking
of
4 integrins in vitro inhibited proliferation and
induced apoptosis of LB cells expressing wild-type
4
subunits or the A4-1021 mutant, but not of LB-A4-1014 cells. In
summary, these results demonstrate that sequence motifs regulating
cytoskeleton-dependent
4 integrin activation in vitro
are essential for the control of LB lymphoma cell expansion both in
vitro and in vivo.
This article has been cited by other articles:
![]() |
M. Lalancette, F. Aoudjit, E. F. Potworowski, and Y. St-Pierre Resistance of ICAM-1-deficient mice to metastasis overcome by increased aggressiveness of lymphoma cells Blood, January 1, 2000; 95(1): 314 - 319. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |